FDA warns India's Sun Pharma on its Gujarat unit

MUMBAI (Reuters) - The U.S. Food and Drug Administration has issued a warning letter to India's Sun Pharmaceutical Industries Ltd about its Halol facility after an inspection revealed problems with its manufacturing processes, the firm said on Saturday.

http://ift.tt/1lYLoR4

from Reuters: Health News
via animenewspro